Ahmed Mohamed Aboelnaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Mohamed Aboelnaga has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Amr Abdallah Gomaa
Plastic surgery department, faculty of medicine, Suez Canal University
1 shared publicationAshraf H. Abbas
Plastic Surgery Unit, Surgery Department, Suez Canal University, Ismailia, Egypt
1 shared publication- Ingrid Steinvall
Department of Hand Surgery, Plastic Surgery and Burns, Linköping University, Linköping, Sweden
1 shared publication - Islam Abdelrahman
The Department of Hand Surgery, Plastic Surgery and Burns, Linköping University, Linköping, Sweden.
1 shared publication Moaz Fathy Abbady
Health insurance hospital, Suez
1 shared publicationMohamed A. Elbadawy
Plastic Surgery Unit, Surgery Department, Suez Canal University, Ismailia, Egypt
1 shared publication
Latest Publications
- Open Access
- 12 December 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Comparison between Intralesional Injection of Botulinum Toxin A and Triamcinolone in Management of Recent Hypertrophic Scars
Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid.
- 12 December 2023
- Published by Egyptian Knowledge Bank in Zagazig University Medical Journal
Open AccessComparison between Intralesional Injection of Botulinum Toxin A and Triamcinolone in Management of Recent Hypertrophic Scars
Background: Hypertrophic scars lead to aesthetic and local symptoms . Moreover these scars have psychological effects such as embarrassment and low self-confidence. Many treatment modalities had been used, but each one has its limited effect. Objectives: The aim of the study is toevaluate the role of hypertrophic scars management by comparing intralesional injection of Botulinum Toxin (BTX-A) to intralesional injection of triamcinolone . Subjects and methods: This study was carried on 20 patients with hypertrophic scars, their scars were divided into two equal sectors, one sector was injected with BTX-A while the other sector was injected with corticosteroid (triamcinolone) as a control. Assessment of the results were achieved objectively and digitally photographed using the same camera, lightening setting and patient positioning before treatment, at one-month, three months and six months' visits. The hypertrophic scar score was calculated before and after treatment by patient and observer scar assessment scale (POSAS). Results: There was statistically significant improvement in both BTX-A and triamcinolone injected scars. The different parameters that assessed by POSAS showed better improvement and significant lower scores in the BTX-A injected areas without side effects. The triamcinolone injected scars showed complication such as atrophy, hypopigmentations. The results of the study revealed that BTX-A has a significant role in treatment of hypertrophic scars with minimal side effects. Conclusion: In conclusion, intralesional injection of BTX-A is suitable for treatment of recent hypertrophic scars with decreasing associated pain and itching and better tolerated than corticosteroid.